Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-29 @ 11:40 PM
Study NCT ID:
NCT07479732
Status:
RECRUITING
Last Update Posted:
2026-03-18
First Post:
2026-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
Sponsor:
Peking University People's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03-05
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-03-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2026-03-06
First Submit QC Date:
None
Study First Post Date:
2026-03-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-15
Last Update Post Date:
2026-03-18
Last Update Post Date Type:
ACTUAL